Indegene announced strong Q3 FY26 results, with revenue reaching INR 9,421 million, a 30.8% YoY increase and a 17.1% QoQ increase. The company achieved its first $100+ million revenue quarter. Revenue per employee crossed $70k annually. Adjusted EBITDA was INR 1,747 million, growing 15.7% YoY. Three clients expanded to $25 million+ annual revenue, and 52 clients reached $1 million+.
Key Financial Highlights
Indegene reported impressive Q3 FY26 results, demonstrating significant growth in revenue and profitability.
Revenue reached INR 9,421 million, representing a 30.8% increase YoY and a 17.1% increase QoQ. This marks the company’s first $100+ million revenue quarter.
Adjusted EBITDA stood at INR 1,747 million, reflecting a 15.7% YoY growth and a 19.6% QoQ growth. The adjusted EBITDA margin was 18.5%.
Revenue per employee (RPE) surpassed $70k annually.
Client Growth and Expansion
Indegene’s top clients are expanding their engagements, contributing to the company’s robust growth.
Three of Indegene’s top five customers have expanded to $25 million+ in annual revenue.
The company now has 52 customers generating $1 million+ in annual revenue.
New Business Wins
Indegene secured significant new deals, indicating strong market demand for its services.
The company secured new marquee deals, including two customer contracts exceeding $10 million ACV each across five work orders. Another deal exceeded $5 million ACV ($20 million TCV) across two work orders.
Strategic Acquisitions
Indegene completed strategic acquisitions to enhance its capabilities and market position.
The company acquired BioPharm, a US-focused life sciences omnichannel business, and Warn & Co., a UK-based consulting firm.
Financial Position
Indegene maintains a strong financial position with healthy cash reserves.
The company’s cash and investments are INR 13,954 million, net of acquisition outflows.
Source: BSE
